1. Home
  2. RIME vs WINT Comparison

RIME vs WINT Comparison

Compare RIME & WINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RIME
  • WINT
  • Stock Information
  • Founded
  • RIME 1982
  • WINT 1992
  • Country
  • RIME United States
  • WINT United States
  • Employees
  • RIME N/A
  • WINT N/A
  • Industry
  • RIME
  • WINT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RIME
  • WINT Health Care
  • Exchange
  • RIME NYSE
  • WINT Nasdaq
  • Market Cap
  • RIME 1.4M
  • WINT 1.5M
  • IPO Year
  • RIME 1994
  • WINT 1995
  • Fundamental
  • Price
  • RIME $2.12
  • WINT $1.39
  • Analyst Decision
  • RIME
  • WINT Hold
  • Analyst Count
  • RIME 0
  • WINT 1
  • Target Price
  • RIME N/A
  • WINT $350.00
  • AVG Volume (30 Days)
  • RIME 164.6K
  • WINT 7.7M
  • Earning Date
  • RIME 05-19-2025
  • WINT 04-15-2025
  • Dividend Yield
  • RIME N/A
  • WINT N/A
  • EPS Growth
  • RIME N/A
  • WINT N/A
  • EPS
  • RIME N/A
  • WINT N/A
  • Revenue
  • RIME $32,479,657.00
  • WINT N/A
  • Revenue This Year
  • RIME N/A
  • WINT N/A
  • Revenue Next Year
  • RIME N/A
  • WINT N/A
  • P/E Ratio
  • RIME N/A
  • WINT N/A
  • Revenue Growth
  • RIME 11.81
  • WINT N/A
  • 52 Week Low
  • RIME $1.71
  • WINT $1.10
  • 52 Week High
  • RIME $394.00
  • WINT $737.50
  • Technical
  • Relative Strength Index (RSI)
  • RIME N/A
  • WINT 30.13
  • Support Level
  • RIME N/A
  • WINT $1.10
  • Resistance Level
  • RIME N/A
  • WINT $2.17
  • Average True Range (ATR)
  • RIME 0.00
  • WINT 0.35
  • MACD
  • RIME 0.00
  • WINT 0.20
  • Stochastic Oscillator
  • RIME 0.00
  • WINT 12.18

About RIME ALGORHYTHM HOLDINGS INC

Algorhythm Holdings Inc is a holding company with two primary investments. It operates through its subsidiaries, one of which is an emerging leader in the AI-enabled global logistics industry. The other subsidiary is engaged in consumer karaoke products, Which designs and distributes the industry's widest assortment of at-home and in-car karaoke entertainment products.

About WINT Windtree Therapeutics Inc.

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.

Share on Social Networks: